Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Codexis (CDXS) Other Non-Current Liabilities (2016 - 2025)

Codexis has reported Other Non-Current Liabilities over the past 16 years, most recently at $1.3 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 4.65% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, up 4.65%, while the annual FY2025 figure was $1.3 million, 4.65% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $1.3 million at Codexis, up from $1.3 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $1.4 million in Q2 2023 and troughed at $1.1 million in Q3 2021.
  • A 5-year average of $1.3 million and a median of $1.3 million in 2021 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: fell 16.65% in 2021 and later rose 29.02% in 2022.
  • Year by year, Other Non-Current Liabilities stood at $1.3 million in 2021, then increased by 4.58% to $1.4 million in 2022, then dropped by 10.07% to $1.2 million in 2023, then grew by 2.84% to $1.3 million in 2024, then grew by 4.65% to $1.3 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for CDXS at $1.3 million in Q4 2025, $1.3 million in Q3 2025, and $1.3 million in Q2 2025.